| Effect of Footwear on the Clinical, Functional, and Biomechanical Aspects in Elderly Women With Knee Osteoarthritis (OA) (NCT01342458) | University of Sao Paulo General Hospital | 2011-03-01 |
| Autologous T-Cells Combined With Autologous OC-DC Vaccine in Ovarian Cancer (NCT01312376) | Abramson Cancer Center at Penn Medicine | 2011-03-01 |
| A Drug Interaction Study Evaluating Plasma GSK2248761 and GSK1349572 Pharmacokinetics in Healthy Adult Subjects. (NCT01283100) | ViiV Healthcare | 2011-03-01 |
| Safety and Tolerability of BVS857 in Subjects With Insulin Resistance (NCT01435330) | Novartis Pharmaceuticals | 2011-03-01 |
| An Investigation Of The Absorption And Pharmacokinetics Of A Single Dose Of A Controlled Release (CR) Pregabalin Tablet Following Various Sized Lunches As Compared To A Single Dose Of The Immediate Release (IR) Pregabalin Capsule In Healthy Volunteers (NCT01270815) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2011-03-01 |
| Ranibizumab 0.5mg and 2.0mg to Treat Diabetic Macular Edema in Patients With Poor Response to Bevacizumab (NCT01292798) | California Retina Consultants | 2011-03-01 |
| Drug-drug Interaction Study (CKD-501, Ketoconazole) (NCT01330563) | Chong Kun Dang Pharmaceutical | 2011-03-01 |
| Male Tolerance Study of Dapivirine Gel Following Multiple Topical Penile Exposures (NCT01277640) | International Partnership for Microbicides, Inc. | 2011-03-01 |
| A Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of JNJ-39439335 in Patients With Osteoarthritis (NCT01343303) | Janssen Research & Development, LLC | 2011-03-01 |
| Fear of Recurrence Pilot Intervention for Women With Breast Cancer (NCT01354041) | University of California, San Francisco | 2011-03-01 |
| Effects of Vortioxetine (Lu AA21004) on the Concentrations of Selected Neurotransmitters in Healthy Male Adults (NCT01299805) | Takeda | 2011-03-01 |
| A Study to Investigate the Safety and Effect of Food on the Pharmacokinetics of YM178 in Healthy Volunteers (NCT01334905) | Astellas Pharma Inc | 2011-03-01 |
| Simplified Negative Pressure Wound Therapy (NCT01339429) | Brigham and Women's Hospital | 2011-03-01 |
| A First Human Study of a Ferroportin Antibody (NCT01330953) | Eli Lilly and Company | 2011-03-01 |
| A Dose-Finding and Exploratory Study of RO5323441 in Combination With Sorafenib in Patients With Hepatocellular Carcinoma (NCT01308723) | Hoffmann-La Roche | 2011-03-01 |
| A Study of Tesetaxel Plus Capecitabine in Patients With Solid Tumors (NCT01315431) | Genta Incorporated | 2011-03-01 |
| The Myocet/Lapatinib Study. ICORG 10-03, V5 (NCT01495884) | Cancer Trials Ireland | 2011-03-01 |
| Effects of Denosumab on the Pharmacokinetics of Etanercept (NCT01294397) | Amgen | 2011-03-01 |
| A Study Of Panobinostat In Children With Refractory Hematologic Malignancies (NCT01321346) | Therapeutic Advances in Childhood Leukemia Consortium | 2011-03-01 |
| Oral Histone Deacetylase Inhibitor 4SC-202 in Patients With Advanced Hematologic Malignancies (TOPAS) (NCT01344707) | 4SC AG | 2011-03-01 |
| Aflac ST1001 Prolonged Isotretinoin (NCT01319838) | Emory University | 2011-03-01 |
| Interaction Between Etravirine or Darunavir/Ritonavir and Artemether / Lumefantrine (NCT01876966) | Janssen Pharmaceutica N.V., Belgium | 2011-03-01 |
| Home-based Exercise for Management of HIV-associated Cardiovascular Disease Risk (NCT01377064) | University of South Carolina | 2011-03-01 |
| A Study Evaluating the Safety of LEO 90105 and Its Vehicle, After Multiple Administration on Intact Skin of Healthy Japanese Male Subjects (NCT01293383) | LEO Pharma | 2011-03-01 |
| Clonal Deletion on Living-Relative Donor Kidney Transplantation (NCT01408797) | Fuzhou General Hospital | 2011-03-01 |
| TMC125IFD1001 - Drug-Drug Interaction of Etravirine With Telaprevir and TMC278 With Telaprevir. (NCT01336829) | Tibotec Pharmaceuticals, Ireland | 2011-03-01 |
| TMC435-TiDP16-C116 - Relative Bioavailability and Food Effect Study (NCT01308606) | Tibotec Pharmaceuticals, Ireland | 2011-03-01 |
| Preventing Brain Injury in Infants With Congenital Heart Disease (NCT01426542) | University of California, Davis | 2011-03-01 |
| Use of Resveratrol to Decrease Acute Secondary Brain Injury Following Sports-Related Concussions in Boxers (NCT01321151) | University of Texas Southwestern Medical Center | 2011-03-01 |
| Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Chemotherapy for Leukemia (NCT01297543) | Cellerant Therapeutics | 2011-03-01 |
| Effects of Administration of Fostamatinib on Blood Concentrations of Warfarin in Healthy Subjects (NCT01311622) | AstraZeneca | 2011-03-01 |
| Clinical Study Evaluating Safety of a New Catheter for Urinary Intermittent Catheter in Healthy Volunteers (NCT01292941) | Coloplast A/S | 2011-03-01 |
| Effects of Administration of Fostamatinib on Blood Concentrations of an Oral Contraceptive in Healthy Female Subjects (NCT01276262) | AstraZeneca | 2011-03-01 |
| Videoendoscopic Pilonidal Sinus Surgery (NCT01583751) | SB Istanbul Education and Research Hospital | 2011-03-01 |
| DOX as a Potential Treatment for Methamphetamine Dependence (NCT02785393) | Baylor College of Medicine | 2011-03-01 |
| A Study of the Specificity and Sensitivity of 5- Aminolevulinic Acid (ALA) Fluorescence in Malignant Brain Tumors (NCT01128218) | Southern Illinois University | 2011-03-01 |
| TMC435-TiDP16-C115 - A Study in Healthy Volunteers Investigating the Pharmacokinetic Interaction Between TMC435 and Erythromycin and Between TMC435 and Darunavir/Ritonavir (DRV/r) (NCT01323257) | Tibotec Pharmaceuticals, Ireland | 2011-03-01 |
| Phase II Clinical Trial to Evaluate the Benefits of Postconditioning in ST-Elevation Myocardial Infarction (STEMI) (NCT01324453) | Minneapolis Heart Institute Foundation | 2011-03-01 |
| A Study of Anti-VEGFR-3 Monoclonal Antibody IMC-3C5 in Subjects With Advanced Solid Tumors (NCT01288989) | Eli Lilly and Company | 2011-03-01 |
| Effects of Transcranial Direct Current Stimulation on Tobacco Withdrawal Symptoms (NCT01567982) | Yale University | 2011-03-01 |
| Safety, Tolerability, Pharmacokinetic, Including Food Interaction, and Pharmacodynamic Profile of BIA 5-1058. (NCT02151994) | Bial - Portela C S.A. | 2011-03-01 |
| A Study to Assess the Pharmacokinetics of the Hydrocodone Extended-Release Tablet (CEP-33237) in Subjects With Normal Renal Function and Subjects With Varying Degrees of Renal Impairment (NCT01319266) | Cephalon | 2011-03-01 |
| Early Study of N-Acetylcysteine to Treat Deliberate Self-Harm in Adolescents (NCT01111734) | University of Minnesota | 2011-03-01 |
| A Pharmacodynamics, Pharmacokinetics, and Safety Study of Hydrochlorothiazide and Canagliflozin in Healthy Volunteers (NCT01294631) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2011-03-01 |
| Safety and Immunogenicity Study of Recombinant Ricin Toxin A-Chain Vaccine (RVEc™) (NCT01317667) | U.S. Army Medical Research and Development Command | 2011-03-01 |
| Eculizumab Therapy for Chronic Complement-Mediated Injury in Kidney Transplantation (NCT01327573) | Sanjay Kulkarni | 2011-03-01 |
| Inpatient Evaluation of an Automated Closed-Loop Control-to-Range System (NCT01271023) | Jaeb Center for Health Research | 2011-03-01 |
| Raising Awareness of Online Therapies for Depression: Pilot Study (NCT01469689) | University of Plymouth | 2011-03-01 |
| Naltrexone for Opioid Dependent Released Human Immunodeficiency Virus Positive (HIV+) Criminal Justice Populations (NCT01246401) | Yale University | 2011-03-01 |
| Safety and Tolerability of Insulin Degludec/Liraglutide (A3) in Healthy Subjects (NCT01319240) | Novo Nordisk A/S | 2011-03-01 |
| Study to Assess the Safety, Tolerability, and Pharmacokinetics of AMP-224 in Patients With Advanced Cancer (NCT01352884) | MedImmune LLC | 2011-03-01 |
| Dose Response Study of VA106483 in Males With Nocturia and Benign Prostatic Hypertrophy (BPH) (NCT01330927) | Vantia Ltd | 2011-03-01 |
| Relative Bioavailability Of A Crizotinib Oral Liquid Formulation To Crizotinib Formulated Capsule (NCT01297595) | Pfizer | 2011-03-01 |
| iSONEP to Treat Persistent Pigment Epithelial Detachment (PED) in Subjects With Exudative Age-Related Macular Degeneration (AMD) or Polypoidal Choroidal Vasculopathy (PCV) (NCT01334255) | Lpath, Inc. | 2011-03-01 |
| Pazopanib and Vinflunine in Urothelial Cancer of the Bladder (NCT01265940) | Prof. Dr. Thomas Otto | 2011-03-01 |
| Study of Human Central Nervous System Stem Cells (HuCNS-SC) in Patients With Thoracic Spinal Cord Injury (NCT01321333) | StemCells, Inc. | 2011-03-01 |
| A Bioequivalence Study of Film-coated Tablet and Dry Syrup 1% Form for E2020 in Healthy Japanese Adult Males (NCT01506739) | Eisai Co., Ltd. | 2011-03-01 |
| A Bioequivalence Study of Amlodipine / Valsartan From Amlodipine/Valsartan 10/160 Tablets (Pharmacare, Palestine) and Exforge Tablets (Novartis Pharma, USA) (NCT02519010) | Genuine Research Center, Egypt | 2011-03-01 |
| Safety Study of VM206RY in Subjects With Expression of HER2 in Breast Cancer (NCT01895491) | Reyon Pharmaceutical Co., Ltd. | 2011-03-01 |
| An Investigation Of The Absorption And Pharmacokinetics Of A Single Dose Of A Controlled Release (CR) Pregabalin Tablet Following A Low, Medium, And High-Fat Evening Meal As Compared To A Single Dose Of The Immediate Release (IR) Pregabalin Capsule In Healthy Volunteers (NCT01257529) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2011-03-01 |
| Multiple Ascending Doses of AMG 139 in Healthy and Crohn's Disease Subjects (NCT01258205) | AstraZeneca | 2011-02-28 |
| Dose Escalation Study of MLN0128 in Combination With Paclitaxel, With/Without Trastuzumab, in Subjects With Advanced Solid Malignancies (NCT01351350) | Millennium Pharmaceuticals, Inc. | 2011-02-28 |
| Relative Bioavailability Study for GSK1278863A (NCT01319006) | GlaxoSmithKline | 2011-02-25 |
| Bioequivalence Study for Terbinafine 250 mg (NCT01772212) | GlaxoSmithKline | 2011-02-24 |
| Real-time MRI Right Heart Catheterization Using Passive Catheters (NCT01287026) | National Heart, Lung, and Blood Institute (NHLBI) | 2011-02-23 |
| Lamivudine and Adefovir Dipivoxil Fixed Dose Combination (NCT01353742) | GlaxoSmithKline | 2011-02-21 |
| Riluzole and Sorafenib Tosylate in Treating Patients With Advanced Solid Tumors or Melanoma (NCT01303341) | National Cancer Institute (NCI) | 2011-02-18 |
| Effect of SRT2379 on Endotoxin-Induced Inflammation (NCT01262911) | Sirtris, a GSK Company | 2011-02-17 |
| A Study of Vemurafenib and GDC-0973 (Cobimetinib) in Participants With BRAFV600E Mutation-Positive Metastatic Melanoma (NCT01271803) | Hoffmann-La Roche | 2011-02-17 |
| BKM120 + Carboplatin + Paclitaxel for Patients With Advanced Solid Tumors (NCT01297452) | Memorial Sloan Kettering Cancer Center | 2011-02-15 |
| Study to Investigate the Absorption, Distribution, Metabolism and Elimination of [14C]GSK1120212 (NCT01387204) | GlaxoSmithKline | 2011-02-15 |
| Effect of Varenicline on Tobacco Addiction and on Abstinence-induced Cognitive Impairment (NCT01309685) | National Institute on Drug Abuse (NIDA) | 2011-02-13 |
| Sorafenib and TRC105 in Hepatocellular Cancer (NCT01306058) | National Cancer Institute (NCI) | 2011-02-11 |
| Interferon Alpha 2b Intensification in HIV-Positive Individuals on Antiretroviral Therapy (NCT01295515) | National Cancer Institute (NCI) | 2011-02-11 |
| BI836826 Dose Escalation in Relapsed Chronic Lymphocytic Leukaemia (CLL) (NCT01296932) | Boehringer Ingelheim | 2011-02-11 |
| An Open Label, Randomised, Repeat Dose Study to Assess the Pharmacokinetic Performance of Five Ezogabine/Retigabine Modified Release (MR) Formulations at Steady State Compared to the Immediate Release (IR) Formulation. (NCT01332513) | GlaxoSmithKline | 2011-02-10 |
| Lenalidomide and Cetuximab in Treating Patients With Advanced Colorectal Cancer or Head and Neck Cancer (NCT01254617) | National Cancer Institute (NCI) | 2011-02-10 |
| Clinical Study of Vorinostat in Combination With Etoposide in Pediatric Patients < 21 Years at Diagnosis With Refractory Solid Tumors (NCT01294670) | Memorial Sloan Kettering Cancer Center | 2011-02-09 |
| High-Dose or Low-Dose Vorinostat in Combination With Carboplatin or Paclitaxel in Treating Patients With Advanced Solid Tumors (NCT01281176) | National Cancer Institute (NCI) | 2011-02-09 |
| Study of Mapatumumab in Combination With Sorafenib in Subjects With Advanced Hepatocellular Carcinoma (NCT01258608) | Human Genome Sciences Inc., a GSK Company | 2011-02-08 |
| Pharmacokinetics of AGO178 in Participants With Liver Impairment (NCT01531309) | Novartis Pharmaceuticals | 2011-02-08 |
| Allo Transplant Followed by Lenalidomide and Sirolimus Maintenance in High-Risk Multiple Myeloma (MM) (NCT01303965) | Sherif S. Farag | 2011-02-07 |
| Lenalidomide and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia (NCT01246622) | Roswell Park Cancer Institute | 2011-02-07 |
| Olaparib in Combination With Carboplatin for Refractory or Recurrent Women s Cancers (NCT01237067) | National Cancer Institute (NCI) | 2011-02-07 |
| Autologous Cell Therapy for Ischemic Heart Failure (NCT01353690) | Cook MyoSite | 2011-02-05 |
| Clofarabine, Idarubicin, and Cytarabine (CIA) Versus Fludarabine, Idarubicin, and Cytarabine (FLAI) in Acute Myelogenous Leukemia (AML) and High-Risk Myelodysplastic Syndrome (NCT01289457) | M.D. Anderson Cancer Center | 2011-02-02 |
| Decitabine Maintenance in Elderly Acute Myeloid Leukemia Patients (NCT01149408) | University of Utah | 2011-02-01 |
| Bioequivalence Study of Fexofenadine Hydrochloride Orally Disintegrated Tablets 30 mg Under Fasting Condition (NCT01888718) | Dr. Reddy's Laboratories Limited | 2011-02-01 |
| Study of TF2 Carcinoembryonic Antigen (CEA) Antibody in Patients With Metastatic Colorectal Cancer (NCT01273402) | Gilead Sciences | 2011-02-01 |
| Feasibility of the Combination of Chemotherapy (Carbo/Caelyx or Carbo/Doxorubicin) With Tocilizumab (mAb IL-6R) and Peg-Intron in Patients With Recurrent Ovarian Cancer (NCT01637532) | Leiden University Medical Center | 2011-02-01 |
| Relative Bioavailability of Single Dose Empagliflozin (BI 10773) When Co-administered With Multiple Doses of 600 mg Gemfibrozil Compared to Single Dose Treatment With Empagliflozin (BI 10773) When Given Alone in Healthy Volunteers (NCT01301742) | Boehringer Ingelheim | 2011-02-01 |
| A Phase 1 Study of Brentuximab Vedotin Given Sequentially and Combined With Multi-Agent Chemotherapy for CD30-Positive Mature T-Cell and NK-Cell Neoplasms (NCT01309789) | Seagen Inc. | 2011-02-01 |
| Safety Study of Ibalizumab Subcutaneous Injection in Healthy Volunteers (NCT01292174) | TaiMed Biologics Inc. | 2011-02-01 |
| A Open Label, Dose Escalating Study to Evaluate the Safety and Tolerability of Ascending Intravenous (i.v.) Doses of Catumaxomab in Epithelial Cancer Patients (NCT01320020) | Neovii Biotech | 2011-02-01 |
| Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Oral Doses of BI 135585 XX in Patients With Type 2 Diabetes (NCT01282970) | Boehringer Ingelheim | 2011-02-01 |
| Esophageal Protocol for Detection of Neoplasia in the Digestive Tract (NCT01391208) | University of Michigan | 2011-02-01 |
| Beta-blockers in i-PAH (NCT01246037) | Amsterdam UMC, location VUmc | 2011-02-01 |
| A Study To Compare The Amount Of CP-690,550 That Is Absorbed Into The Blood Of Healthy Subjects Following Oral Administration Of Two Different Strength Tablets Of CP-690,550 (NCT01277991) | Pfizer | 2011-02-01 |
| Anti-TGF-beta Therapy in Patients With Myelofibrosis (NCT01291784) | John Mascarenhas | 2011-02-01 |
| Thoracoscopic Lobectomy Using Nonintubated Anesthesia Versus Intubated General Anesthesia for Lung Cancer Patients (NCT01533233) | National Taiwan University Hospital | 2011-02-01 |